retatrutide in south africa clinical trial Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver Over several weeks, a Mail
Description
While early clinical trials and ongoing research have produced promising results in weight loss, blood sugar control, and metabolic health, it is still in the investigational stage
Fatty liver is a common complication in people with obesity
Cardiovasc Ultrasound (2019) 17(1):26
Moreover, the FDA issued warnings about bad actors selling the active pharmaceutical ingredient (API) directly to consumers via the Internet, either in powder form labeled not for human consumption or in vials labeled as a research chemical, along with dosing instructions
